Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

The FDA has approved relacorilant (Lifyorli, Corcept Therapeutics) in combination with nab-paclitaxel for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal ...

Glucocorticoid exposure was linked to higher incident toxicity rates, including ≥1 toxicity (61.9% vs 52.3%) and ≥3 ...

Steroids may be a daily necessity when you have CAH, and the side effects can be significant — here’s how to reduce their ...

Due to their immunosuppressive properties, systemic glucocorticoids are estimated to be used by 0.5% to 3% of the population annually. Glucocorticoids are effective, but their use comes with some ...

Please provide your email address to receive an email when new articles are posted on . In a proof-of-concept study across four U.K. hospitals, Korbonits and colleagues analyzed data from 53 adults ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Maintaining immunosuppression with or without low-dose glucocorticoids is superior to withdrawing ...

Takes recent clinical trials, drug introductions into account ...

Up to 20% of children who experience an anaphylactic episode can have a biphasic reaction, a rebound of symptoms hours after resolution of the original episode. Although glucocorticoids have been used ...

The study by Israel et al. (Sept. 27 issue) 1 of bone thinning in women with asthma did not effectively control for the critical variables of the level of physical activity and the severity of asthma.